197 related articles for article (PubMed ID: 23651231)
1. N-acetylcysteine versus placebo for treating nail biting, a double blind randomized placebo controlled clinical trial.
Ghanizadeh A; Derakhshan N; Berk M
Antiinflamm Antiallergy Agents Med Chem; 2013; 12(3):223-8. PubMed ID: 23651231
[TBL] [Abstract][Full Text] [Related]
2. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
[TBL] [Abstract][Full Text] [Related]
3. Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting.
Berk M; Jeavons S; Dean OM; Dodd S; Moss K; Gama CS; Malhi GS
CNS Spectr; 2009 Jul; 14(7):357-60. PubMed ID: 19773711
[TBL] [Abstract][Full Text] [Related]
4. A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder.
Wink LK; Adams R; Wang Z; Klaunig JE; Plawecki MH; Posey DJ; McDougle CJ; Erickson CA
Mol Autism; 2016; 7():26. PubMed ID: 27103982
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials.
Grandjean EM; Berthet P; Ruffmann R; Leuenberger P
Clin Ther; 2000 Feb; 22(2):209-21. PubMed ID: 10743980
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
Behr J; Bendstrup E; Crestani B; Günther A; Olschewski H; Sköld CM; Wells A; Wuyts W; Koschel D; Kreuter M; Wallaert B; Lin CY; Beck J; Albera C
Lancet Respir Med; 2016 Jun; 4(6):445-53. PubMed ID: 27161257
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial.
Berk M; Dean OM; Cotton SM; Jeavons S; Tanious M; Kohlmann K; Hewitt K; Moss K; Allwang C; Schapkaitz I; Robbins J; Cobb H; Ng F; Dodd S; Bush AI; Malhi GS
J Clin Psychiatry; 2014 Jun; 75(6):628-36. PubMed ID: 25004186
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
Ataei S; Hadjibabaie M; Moslehi A; Taghizadeh-Ghehi M; Ashouri A; Amini E; Gholami K; Hayatshahi A; Vaezi M; Ghavamzadeh A
Hematol Oncol; 2015 Jun; 33(2):67-74. PubMed ID: 24711000
[TBL] [Abstract][Full Text] [Related]
9. A review of N-acetylcysteine in the treatment of grooming disorders.
Braun TL; Patel V; DeBord LC; Rosen T
Int J Dermatol; 2019 Apr; 58(4):502-510. PubMed ID: 30667049
[TBL] [Abstract][Full Text] [Related]
10. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.
Gray KM; Carpenter MJ; Baker NL; DeSantis SM; Kryway E; Hartwell KJ; McRae-Clark AL; Brady KT
Am J Psychiatry; 2012 Aug; 169(8):805-12. PubMed ID: 22706327
[TBL] [Abstract][Full Text] [Related]
11. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
[TBL] [Abstract][Full Text] [Related]
12. Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study.
Marian AJ; Tan Y; Li L; Chang J; Syrris P; Hessabi M; Rahbar MH; Willerson JT; Cheong BY; Liu CY; Kleiman NS; Bluemke DA; Nagueh SF
Circ Res; 2018 Apr; 122(8):1109-1118. PubMed ID: 29540445
[TBL] [Abstract][Full Text] [Related]
13. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
Gray KM; Sonne SC; McClure EA; Ghitza UE; Matthews AG; McRae-Clark AL; Carroll KM; Potter JS; Wiest K; Mooney LJ; Hasson A; Walsh SL; Lofwall MR; Babalonis S; Lindblad RW; Sparenborg S; Wahle A; King JS; Baker NL; Tomko RL; Haynes LF; Vandrey RG; Levin FR
Drug Alcohol Depend; 2017 Aug; 177():249-257. PubMed ID: 28623823
[TBL] [Abstract][Full Text] [Related]
14. N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial.
Morley KC; Peruch S; Adams C; Towers E; Tremonti C; Watt J; Jamshidi N; Haber PS
Alcohol Alcohol; 2023 Sep; 58(5):553-560. PubMed ID: 37465907
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the efficacy of habit reversal: comparison with a placebo control.
Twohig MP; Woods DW; Marcks BA; Teng EJ
J Clin Psychiatry; 2003 Jan; 64(1):40-8. PubMed ID: 12590622
[TBL] [Abstract][Full Text] [Related]
16. N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial.
Bloch MH; Panza KE; Grant JE; Pittenger C; Leckman JF
J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):231-40. PubMed ID: 23452680
[TBL] [Abstract][Full Text] [Related]
17. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.
McClure EA; Sonne SC; Winhusen T; Carroll KM; Ghitza UE; McRae-Clark AL; Matthews AG; Sharma G; Van Veldhuisen P; Vandrey RG; Levin FR; Weiss RD; Lindblad R; Allen C; Mooney LJ; Haynes L; Brigham GS; Sparenborg S; Hasson AL; Gray KM
Contemp Clin Trials; 2014 Nov; 39(2):211-23. PubMed ID: 25179587
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study.
Suter PM; Domenighetti G; Schaller MD; Laverrière MC; Ritz R; Perret C
Chest; 1994 Jan; 105(1):190-4. PubMed ID: 8275731
[TBL] [Abstract][Full Text] [Related]
19. N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study.
Prado E; Maes M; Piccoli LG; Baracat M; Barbosa DS; Franco O; Dodd S; Berk M; Vargas Nunes SO
Redox Rep; 2015 Sep; 20(5):215-22. PubMed ID: 25729878
[TBL] [Abstract][Full Text] [Related]
20. Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study.
Domenighetti G; Suter PM; Schaller MD; Ritz R; Perret C
J Crit Care; 1997 Dec; 12(4):177-82. PubMed ID: 9459113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
